Metabolic Risk Contributes to Diabetes Onset in People With HIV
Metabolic risk factors contribute to new-onset diabetes mellitus among those treated with pitavastatin or placebo
Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and...
Only goal met by 2022 was a 50 percent reduction in hunger or food insecurity among persons with HIV aged 65 years and older
Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access?
Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time
High-intensity adopters had reduction in documentation for full postadoption periods and following learning period
Federal Judge Rules That U.S. Military Cannot Reject HIV-Positive Enlistees
Long-Acting Cabotegravir Well Tolerated in Pregnant Women
Pregnancy-related maternal adverse events, poor pregnancy outcomes similar for those using CAB-LA versus those without exposure
Abacavir Use Linked to Increased Incidence of MACE
Former and current use of abacavir linked to higher incidence of MACE, but no association seen for other ART agents
Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
Among men who have sex with men with HIV, only receipt of semen into the rectum is associated with reinfection
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable Cabotegravir
Cases involving LEVI were characterized by low or undetectable HIV viral load and reduced or delayed antibody production
Twice-Yearly Lenacapavir Prevents HIV Infection in Young Women
HIV incidence with lenacapavir significantly lower than background HIV incidence, incidence with F/TDF
